PAMELA SAENZ: Open Payments
NPI 1417531906 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 53 payments from 13 companies in 2025. Trend: 2023 $282 · 2024 $534 · 2025 $1,082
Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $172 |
| Lilly USA, LLC | 8 | $162 |
| Novo Nordisk Inc | 7 | $132 |
| AstraZeneca Pharmaceuticals LP | 5 | $82 |
| Amgen Inc. | 5 | $82 |
| Sumitomo Pharma America, Inc. | 1 | $81 |
| GlaxoSmithKline, LLC. | 3 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
| Exact Sciences Corporation | 4 | $67 |
| PFIZER INC. | 3 | $61 |
Products named: Kerendia, JARDIANCE, MOUNJARO, GEMTESA, Cologuard Collection Kit, BREZTRI, TRELEGY ELLIPTA, Veozah.
Industry payments across TX — which companies pay providers there.
